Personal Capital Advisors Corp Abbott Laboratories Transaction History

Personal Capital Advisors Corp

$20.6 Billion
Q4 2022

A detailed history of Personal Capital Advisors Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Personal Capital Advisors Corp holds 849,034 shares of ABT stock, worth $99.2 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares

849,034

Previous 829,640 2.34%

Holding current value

$99.2 Million

Previous $80.3 Million 16.14%

% of portfolio

0.45%

Previous 0.43%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $1.84 Million - $2.16 Million	19,394 Added 2.34%	849,034 $93.2 Million
Q3 2022 Nov 07, 2022	BUY	$96.76 - $112.03 $8.36 Million - $9.68 Million	86,392 Added 11.62%	829,640 $80.3 Million
Q2 2022 Aug 04, 2022	SELL	$102.07 - $123.37 $5.36 Million - $6.48 Million	-52,507 Reduced 6.6%	743,248 $80.8 Million
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $2.24 Million - $2.73 Million	19,652 Added 2.53%	795,755 $94.2 Million
Q4 2021 Feb 11, 2022	BUY	$115.53 - $141.46 $1.87 Million - $2.29 Million	16,200 Added 2.13%	776,103 $109 Million
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $3.35 Million - $3.71 Million	28,750 Added 3.93%	759,903 $89.8 Million
Q2 2021 Aug 11, 2021	BUY	$105.79 - $124.53 $4.22 Million - $4.97 Million	39,879 Added 5.77%	731,153 $84.8 Million
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $2.52 Million - $2.97 Million	23,193 Added 3.47%	691,274 $82.8 Million
Q4 2020 Feb 12, 2021	BUY	$105.0 - $114.42 $840,000 - $915,360	8,000 Added 1.21%	668,081 $73.1 Million
Q3 2020 Nov 13, 2020	SELL	$91.64 - $111.29 $335,127 - $406,987	-3,657 Reduced 0.55%	660,081 $71.8 Million
Q2 2020 Aug 12, 2020	BUY	$76.57 - $98.0 $39,127 - $50,078	511 Added 0.08%	663,738 $60.7 Million
Q1 2020 May 12, 2020	BUY	$62.82 - $91.86 $1.12 Million - $1.64 Million	17,906 Added 2.77%	663,227 $52.5 Million
Q4 2019 Feb 13, 2020	BUY	$78.51 - $87.4 $3.09 Million - $3.44 Million	39,331 Added 6.49%	645,321 $56.1 Million
Q3 2019 Nov 07, 2019	BUY	$81.84 - $88.74 $2.1 Million - $2.28 Million	25,682 Added 4.43%	605,990 $50.7 Million
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $3.01 Million - $3.51 Million	41,292 Added 7.66%	580,308 $48.8 Million
Q1 2019 May 13, 2019	BUY	$66.22 - $80.06 $35.3 Million - $42.7 Million	533,045 Added 8927.23%	539,016 $43.1 Million
Q4 2018 Jan 16, 2019	BUY	$65.56 - $74.27 $212,152 - $240,337	3,236 Added 118.32%	5,971 $432,000
Q3 2018 Oct 09, 2018	BUY	$60.81 - $73.36 $166,315 - $200,639	2,735 New	2,735 $201,000
Q1 2018 May 09, 2018	SELL	$56.27 - $63.62 $347,467 - $392,853	-6,175 Closed	0 $0
Q4 2017 Jan 19, 2018	BUY	$53.68 - $57.47 $331,474 - $354,877	6,175	6,175 $352,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Personal Capital Advisors Corp, based on Form 13F filings with the SEC.

News

Stay updated on Personal Capital Advisors Corp with notifications on news.

Account

Personal Capital Advisors Corp Abbott Laboratories Transaction History